News
After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.
AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.
23m
Tribune Content Agency on MSNEnvironmental Nutrition: Chewing gum may offer surprising health benefitsChewing gum in one form or another has been around for thousands of years. For centuries, gum consisted of the latex, called ...
Massachusetts faced some of the heaviest losses nationally, with cuts affecting more than $100 million in NIH grants.
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg (Niaspan ...
The product is bioequivalent and therapeutically equivalent to the reference listing drug VYZULTA Opthalmic solution, 0.024% ...
1hon MSN
India to force restaurants to disclose if they use ‘analogue paneer’ in fake cheese crackdown - ‘Analogue paneer’ is a ...
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Latanoprostene Bunod Ophthalmic Solution, 0.024%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results